BITRF (Biotron) PB Ratio: (As of Jun. 28, 2026)


What is Biotron PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), Biotron's share price is $0.002. Biotron's Book Value per Share for the quarter that ended in Dec. 2025 was $0.00. Hence, Biotron's PB Ratio of today is .

The historical rank and industry rank for Biotron's PB Ratio or its related term are showing as below:

BITRF' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3
Current: 3

During the past 13 years, Biotron's highest PB Ratio was 3.00. The lowest was 0.00. And the median was 0.00.

BITRF's PB Ratio is ranked worse than
52.6% of 1232 companies
in the Biotechnology industry
Industry Median: 2.815 vs BITRF: 3.00

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Biotron was 71.00% per year. The lowest was -50.00% per year. And the median was -20.60% per year.

Back to Basics: PB Ratio


Biotron  (OTCPK:BITRF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biotron PB Ratio Related Terms


Biotron PB Ratio Historical Data

* Premium members only.

The historical data trend for Biotron's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotron PB Ratio Chart

Biotron Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.83 29.00 7.02 0.00 0.00

Biotron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.72 0.00 0.00 0.00 11.33

BITRF vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Biotron's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotron PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotron's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotron's PB Ratio falls into.



Biotron PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biotron's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.002/0.001
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biotron Business Description

Other Exchanges BIT:Australia
Address 66 Hunter Street, Level 2, Sydney, NSW, AUS, 2000
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.